Article
Version 1
Preserved in Portico This version is not peer-reviewed
SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences
Version 1
: Received: 7 June 2020 / Approved: 7 June 2020 / Online: 7 June 2020 (09:20:25 CEST)
How to cite: Hassan, S.S.; Pal Choudhury, P.; Roy, B. SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences. Preprints 2020, 2020060072 (doi: 10.20944/preprints202006.0072.v1). Hassan, S.S.; Pal Choudhury, P.; Roy, B. SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences. Preprints 2020, 2020060072 (doi: 10.20944/preprints202006.0072.v1).
Abstract
In the NCBI database, as on June 6, 2020, total number of available complete genome sequences of SARS-CoV2 across the world is 3617. The envelope protein of SARS-CoV2 possesses several non-synonymous mutations over the transmembrane domain and (C)-terminus in 0.414\% of these 3617 genomes. The C-terminus motif DLLV has been changed to DFLV and YLLV in the proteins QJR88103 (Australia: Victoria) and QKI36831 (China: Guangzhou) respectively, which might affect the binding of this motif with the host protein PALS1.
Keywords
Envelope protein; SARS-CoV2; COVID-19; Non-synonymous mutations
Subject
BIOLOGY, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.
Leave a public commentSend a private comment to the author(s)